Op0058 Dazodalibep (anti-cd40l) Effectively Reduces Multiple Proteins Associated With B-, T-, and Dendritic Cell Biomarkers in Sjögren’s Disease: Corroboration of Immunophenotyping Findings From the Aliss Phase 2 Study